{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:31:27Z","timestamp":1793745087895,"version":"4.6.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015394","name":"American Society for Blood and Marrow Transplantation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtct.2022.11.015","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:26:09Z","timestamp":1669393569000},"page":"151-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research"],"prefix":"10.1016","volume":"29","author":[{"given":"M.L.","family":"Schoettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-6616","authenticated-orcid":false,"given":"B.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jodele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Moissev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sanchez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-5020","authenticated-orcid":false,"given":"A.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Y.","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Koreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kroger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-3245","authenticated-orcid":false,"given":"P.","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-8828","authenticated-orcid":false,"given":"K.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BE.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.11.015_bib0001","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fped.2019.00133","article-title":"Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management","volume":"7","author":"Dvorak","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2022.11.015_bib0002","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0040-1702225","article-title":"Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy","volume":"120","author":"Gavriilaki","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtct.2022.11.015_bib0003","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.015_bib0004","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2022.11.015_bib0006","doi-asserted-by":"crossref","first-page":"e13371","DOI":"10.1111\/ctr.13371","article-title":"Transplant-associated thrombotic microangiopathy: incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation","volume":"32","author":"Gavriilaki","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0007","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/bjh.16457","article-title":"Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy","volume":"189","author":"Epperla","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0008","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/JBM.S102235","article-title":"Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment","volume":"7","author":"Rosenthal","year":"2016","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtct.2022.11.015_bib0009","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.5858\/arpa.2016-0599-RA","article-title":"A complete histologic approach to gastrointestinal biopsy from hematopoietic stem cell transplant patients with evidence of transplant-associated gastrointestinal thrombotic microangiopathy","volume":"141","author":"Warren","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtct.2022.11.015_bib0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12185-019-02750-7","article-title":"Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease","volume":"110","author":"Gavriilaki","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0011","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0012","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","article-title":"Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD","volume":"2","author":"Wall","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.11.015_bib0013","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbmt.2019.08.025","article-title":"Distribution of transplantation-associated thrombotic microangiopathy (TA-TMA) and comparison between renal TA-TMA and intestinal TA-TMA: autopsy study","volume":"26","author":"Yamada","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0014","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0015","doi-asserted-by":"crossref","first-page":"45.e1","DOI":"10.1016\/j.jtct.2022.09.026","article-title":"Pulmonary manifestations and vascular changes in pediatric transplantation-associated thrombotic microangiopathy","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.11.015_bib0016","doi-asserted-by":"crossref","first-page":"e29128","DOI":"10.1002\/pbc.29128","article-title":"Testicular thrombotic microangiopathy: an unrecognized complication","volume":"68","author":"Sabulski","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.11.015_bib0017","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.11.015_bib0018","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.015_bib0019","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","article-title":"Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal","volume":"25","author":"Li","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0021","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu T","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.11.015_bib0022","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/jpm11060467","article-title":"Thrombotic microangiopathy: multi-institutional review of pediatric patients who underwent HSCT","volume":"11","author":"Ramgopal","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jtct.2022.11.015_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.11.015_bib0024","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/bloodadvances.2019001242","article-title":"Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort","volume":"4","author":"Schoettler","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.11.015_bib0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/17474086.2021.1960816","article-title":"Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients","volume":"14","author":"Jodele","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0026","doi-asserted-by":"crossref","first-page":"308.e1","DOI":"10.1016\/j.jtct.2020.12.010","article-title":"Prognostic biomarkers for thrombotic microangiopathy after acute graft-versus-host disease: a nested case-control study","volume":"27","author":"Li","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.11.015_bib0027","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.11.015_bib0028","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.015_bib0029","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/bmt.2010.182","article-title":"Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT","volume":"46","author":"Laskin","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0030","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1182\/bloodadvances.2019001315","article-title":"New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT","volume":"4","author":"Elfeky","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.11.015_bib0031","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/bloodadvances.2021004933","article-title":"Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults","volume":"6","author":"Vasu","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.11.015_bib0032","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41409-018-0159-8","article-title":"High-dose carboplatin\/etoposide\/melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma","volume":"53","author":"Jodele","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1473-0502(02)00020-4","article-title":"Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and veno-occlusive disease of the liver","volume":"27","author":"Daly","year":"2002","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtct.2022.11.015_bib0034","doi-asserted-by":"crossref","unstructured":"Schoettler M, Stenger EO, Spencer K, et al. Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children [e-pub ahead of print]. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2022008058, Accessed 11\/22\/2022","DOI":"10.1182\/bloodadvances.2022008058"},{"key":"10.1016\/j.jtct.2022.11.015_bib0035","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.bbmt.2018.12.086","article-title":"Transplantation-associated thrombotic microangiopathy (TA-TMA): lessons learned from a large pediatric center","volume":"25","author":"Schoettler","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl","key":"10.1016\/j.jtct.2022.11.015_bib0036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2019.37.27_suppl.14","article-title":"Level of scientific evidence supporting NCCN guidelines: is there evidence of progress?","volume":"37","author":"Desai","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0037","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s41409-018-0374-3","article-title":"Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT","volume":"54","author":"Moiseev","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0038","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/ijlh.13682","article-title":"2021 update of the 2012 ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes: impact and revisions","volume":"43","author":"Zini","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0039","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-018-0106-9","article-title":"Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature","volume":"7","author":"Wirtschafter","year":"2018","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0040","first-page":"1333","article-title":"Proteinuria in adults: a diagnostic approach","volume":"62","author":"Caroll","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jtct.2022.11.015_bib0041","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.015_bib0042","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18620\/ctt-1866-8836-2021-10-2-17-25","article-title":"Practical review of current approaches to diagnosis and treatment of transplant-associated thrombotic microangiopathy","volume":"10","author":"Moiseev","year":"2021","journal-title":"Cell Ther Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0043","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2018-01-822957","article-title":"MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD","volume":"131","author":"Major-Monfried","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.015_bib0044","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.11.015_bib0045","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMc1700185","article-title":"ST2 and endothelial injury as a link between GVHD and microangiopathy","volume":"376","author":"Rotz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.11.015_bib0046","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.015_bib0047","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"19","author":"Arai","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0048","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/cei.13497","article-title":"MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab","volume":"203","author":"Elhadad","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0049","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2215\/CJN.05830519","article-title":"Complement activation and thrombotic microangiopathies","volume":"14","author":"Palomo","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0050","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.imbio.2016.06.007","article-title":"Modeling complement-driven diseases in transgenic mice: values and limitations","volume":"221","author":"Ueda","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.jtct.2022.11.015_bib0051","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41409-021-01390-y","article-title":"Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation","volume":"56","author":"Luft","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0052","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/17474086.2021.1968823","article-title":"Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis","volume":"14","author":"Eftychidis","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0053","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bjh.16621","article-title":"Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation","volume":"190","author":"Hildebrandt","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0054","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.bbmt.2018.05.010","article-title":"Impact of thrombotic microangiopathy on renal outcomes and survival after hematopoietic stem cell transplantation","volume":"24","author":"Postalcioglu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0055","article-title":"Transplant-associated thrombotic microangiopathy (TA-TMA) and consensus-based diagnostic and therapeutic recommendations: which TA-TMA patients to treat and when?","volume":"2:3","author":"Uderzo","year":"2014","journal-title":"J Bone Marrow Res"},{"key":"10.1016\/j.jtct.2022.11.015_bib0056","article-title":"Prevalence of proteinuria and albuminuria in an obese population and associated risk factors","volume":"5:122","author":"Rosenstock","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtct.2022.11.015_bib0057","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1681\/ASN.2010030250","article-title":"Proteinuria in diabetes: bystander or pathway to cardiorenal disease?","volume":"21","author":"Karalliedde","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0058","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2022.11.015_bib0059","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.3324\/haematol.2017.174201","article-title":"In vitro evidence of complement activation in patients with sickle cell disease","volume":"102","author":"Gavriilaki","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.11.015_bib0060","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1097\/HS9.0000000000000487","article-title":"Endothelial and complement activation as predictors of survival in adult allogeneic hematopoietic cell transplantation","volume":"5","author":"Gavriilaki","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtct.2022.11.015_bib0061","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/bmt.2013.197","article-title":"Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease","volume":"49","author":"Hingorani","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0062","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbmt.2008.09.015","article-title":"Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival","volume":"14","author":"Hingorani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0063","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bmt.1702648","article-title":"Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation","volume":"26","author":"Uderzo","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0064","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation","volume":"73","author":"Holler","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.015_bib0065","first-page":"247","article-title":"Bone marrow transplant-associated thrombotic microangiopathy: a case series","volume":"15","author":"Zeigler","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0066","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ejh.12996","article-title":"Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: risk factors and outcome","volume":"100","author":"Zhang","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0067","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hon.2310","article-title":"Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study","volume":"35","author":"Ye","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0068","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0069","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41409-018-0293-3","article-title":"High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease","volume":"54","author":"Kraft","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0070","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/ajh.25922","article-title":"Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Heybeli","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0071","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41409-019-0703-1","article-title":"EASIX and mortality after allogeneic stem cell transplantation","volume":"55","author":"Luft","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0072","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/bloodadvances.2019032268","article-title":"External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Shouval","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.11.015_bib0073","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<213::AID-AJH1>3.0.CO;2-0","article-title":"Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura\/hemolytic uremic syndromes (TTP\/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM)","volume":"53","author":"Zeigler","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0074","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1053\/j.ajkd.2006.06.013","article-title":"Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy","volume":"48","author":"Erdbruegger","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jtct.2022.11.015_bib0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bmt.2014.17","article-title":"Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus","volume":"49","author":"Labrador","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0076","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.015_bib0077","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3389\/fimmu.2019.02339","article-title":"Acute graft-vs-host disease-associated endothelial activation in vitro is prevented by defibrotide","volume":"10","author":"Martinez-Sanchez","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.11.015_bib0078","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3324\/haematol.2020.253716","article-title":"Endothelial damage and dysfunction in acute graft-versus-host disease","volume":"106","author":"Cordes","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.11.015_bib0079","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/eji.201646789","article-title":"Pathogen interactions with endothelial cells and the induction of innate and adaptive immunity","volume":"48","author":"Konradt","year":"2018","journal-title":"Eur J Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T22:45:27Z","timestamp":1730587527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722017833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2666636722017833"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.11.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}